Clin2
NCT05547919Possibly a fitRecruiting

PSMA scan study for newly diagnosed gut cancer

Gastrointestinal Cancer

Part of Cancer, Digestive system clinical trials.

This study looks at a specific body scan target (PSMA) in newly diagnosed gut cancers to better understand the tumor and guide future care. You may be asked to provide tumor tissue and get a PSMA PET/CT scan, and the results could help identify who may benefit from PSMA-based treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
46 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have newly diagnosed gastroenterologic (gut) cancer and have not started standard cancer treatment yet
  • You are 18 years or older
  • You can provide a tumor tissue sample for PSMA testing (expression profiling)
  • You can sign a consent form and follow study visits and follow-up
  • You are not in a curative-only treatment plan (your care is not just aiming to fully cure the cancer)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06835244Enrolling by invitation
Study of PSMA PET/CT scans for non-prostate cancers

This study looks at how well a special scan (PSMA PET/CT) works for people with cancers other than prostate cancer. If your doctor already scheduled this scan for your care, you may be able to help researchers learn more about its accuracy.

Bologna
NCT06690970Recruiting
PSMA PET/CT scan for people with or suspected to have cancer

This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.

Hefei, Anhui
NCT07474142Recruiting
PSMA PET scan for newly diagnosed prostate cancer

This study looks at whether a special scan called PSMA PET can help predict how prostate cancer will progress. It is for people who have just been diagnosed and have not started treatment yet.

Lanzhou, Gansu
NCT05228106Recruiting
PSMA scan using 68Ga-PSMA-617 PET/CT

This study looks at a PSMA-targeted PET/CT scan using 68Ga-PSMA-617 for tumors that show a specific marker (PSMA). It’s meant to help confirm or evaluate suspected or known PSMA-expressing tumors in real-life clinical practice.

Sherbrooke, Quebec
NCT06820333Recruiting
PSMA PET scan for newly diagnosed prostate cancer

This trial looks at how well a special scan called PSMA PET/CT can help find the spread of prostate cancer when it is first diagnosed. You may be able to join if your doctor has already recommended this scan for you.

Düsseldorf, North Rhine-Westphalia
NCT06167629Recruiting
PSMA PET scan study for prostate cancer

This study uses a special type of PET scan called PSMA PET to better understand and track prostate cancer. The scan helps doctors see where the cancer is in the body and if treatment is working.

Milan

Hear when a new Gastrointestinal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.